FSP 2024 Summer Pathology Conference


Save the Date for the FSP 2024 Summer Pathology Conference taking place on July 12-14, 2024 at the Eau Palm Beach Resort & Spa. The FSP 2023 Summer Pathology Conference will provide pathologists with education surrounding a wide range of topics and the opportunity to learn and adopt new strategies and tools to aid in the diagnosis and analysis of diseases. More information coming soon!


Personal Information

Contact Information

Registration Type

Proof of Training Status


Special Events Tickets

Guest Event Tickets
More Info
$75 each

Additional Products

Item Price
Printed syllabus
A printed syllabus can be purchased for an additional cost at the time of registration. A printed syllabus is not provided unless purchased at the time of registration. A digital syllabus will be provided to all attendees who are registered at no additional cost.

Florida Society of Pathologists Terms & Conditions and Cancellation Policy

Assumption of Risk:
I accept and assume all risks of my in-person participation, including the risk of injury or contracting an infectious disease, including but not limited to COVID-19 exposure.

Badge Information:
By allowing an exhibitor to scan the conference badge, attendee understands, agrees and consents to the sharing of attendee's contact information with the company that scanned the conference badge.

Cancellation Policy:
A written notice of cancellation must be received by June 12, 2024 to receive a refund. Cancellations received prior to this date will be honored minus a $100 administration fee. Refunds will not be honored after June 12, 2024. Telephone cancellations cannot be accepted.

Special Needs
We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you. Please contact info@flpath.org at least four (4) weeks in advance prior to the event.

Communication, Confirmation and Receipts:
You must provide a valid Email address when you register online to receive a confirmation/receipt. Please remember to check your spam/junk box for confirmation emails and receipts.

You consent to the photographing and recording of your likeness and voice and the use of these photographs and/or recordings singularly or in conjunction with other photographs and/or recordings for advertising, publicity, commercial or other business purposes.

Payment Information

Abstract Poster Submission #1
Poster Title
Author Name(s)
Financial Disclosures
Disclosure of Funding Support
Choose one of the following Topics


Eric F. Glassy, MD
Affiliated Pathologists Medical Group
Trustee, American Board of Pathology
Former Governor of the CAP
Rancho Dominguez, CA

John Hart, MD
Professor and Vice Chair of Anatomic Pathology
University of Chicago Medicine
Chicago, IL
Topic: GI Pathology

Kun Jiang, MD, PhD
Director, GI Pathology Fellowship
Director, Pathology Gross Room
Associate Member, Moffitt Cancer Center
Associate Professor, University of South Florida
Tampa, FL
Topic: Microscopy read slides session on GI Tumor/Frozen section

Aysegul Sahin, MD
Professor of Pathology
Distinguished Educator-UT Kenneth Shine Academy for Health Science Education
UT MD Anderson Cancer Center
Houston, TX
Topic: Breast Pathology

Christopher J. VandenBussche, MD, PhD
Associate Professor of Pathology
The Johns Hopkins University School of Medicine
Baltimore, MD
Topic: Urine Cytology and Serous Fluid Cytology

Adjunct Faculty

Senior Patient Safety Risk Manager
The Doctors Company
Jacksonville, FL
Topic: Prevention of Medical Errors


To view the presentation slides please log in to your account

Friday, July 12, 2024

3:00 pm - 6:00 pm
Registration Open  


4:00 pm - 6:00 pm
STATE MANDATED COURSE: Prevention of Medical Errors for Pathologists


Saturday, July 13, 2024

7:00 am – 7:30 pm
Registration Open  


7:00 am – 8:00 am
Breakfast with Exhibitors  


8:00 am – 8:15 am
Welcome and Introductions  


8:15 am – 9:15 am
The Paris System for Reporting Urinary Cytology
Christopher J. VandenBussche, MD, PhD


9:15 am – 10:15 am
The International System for Reporting Serous Fluid Cytology
Christopher J. VandenBussche, MD, PhD


10:15 am – 10:45 am
Refreshment Break with Exhibitors  


10:45 am – 11:45 am
Instructive Cases in Urinary and Serous Fluid Cytology Microscopy Session
Christopher J. VandenBussche, MD, PhD

Presentation Slides


11:45 am – 12:00 pm
FSP Business Meeting  


12:15 pm – 1:00 pm

Sponsored Lunch Session


1:00 pm – 1:30 pm
Dessert Break with Exhibitors  


1:30 pm – 2:30 pm
Biopsy diagnosis of inflammatory bowel disease and mimics
John Hart, MD


2:30 pm – 3:30 pm
Hepatocellular carcinoma and mimics – what surgical pathologists should be watching out for in 2024
John Hart, MD


3:30 pm – 4:00 pm
Refreshment Break with Exhibitors  


4:00 pm – 5:00 pm
Really Cool GI pathology Cases Microscopy Session
John Hart, MD


5:00 pm – 5:45 pm
Microscopy read slides session on GI Tumor/Frozen section
Kun Jiang, MD, PhD

Presentation Slides


5:45 pm – 6:30 pm

Sponsored Session


6:30 pm – 7:30 pm
Welcome Reception with Exhibitors  


Sunday, July 14, 2024

7:00 am – 12:30 pm
Registration Open  


7:00 am – 8:00 am
Breakfast with Exhibitors  


8:00 am – 8:45 am
Sorcerer’s Apprentice: the Magic and Mayhem of ChatGPT
Eric Glassy, MD


8:45 am – 9:45 am
Triple Negative Breast Cancer
Aysegul Sahin, MD


9:45 am – 10:45 am
Intraductal Proliferative Lesions of Breast
Aysegul Sahin, MD


10:45 am – 11:15 am
Refreshment Break with Exhibitors  


11:15 am – 12:15 pm
Breast Pathology Microscopy Session
Aysegul Sahin, MD


12:15 pm – 12:30 pm
Closing Remarks  



The FSP 2024 Summer Pathology Conference will take place at the EAU Palm Beach.


Eau Palm Beach Resort & Spa

100 South Ocean Boulevard
Manalapan, Florida 33462
Phone: 561-533-6000

Visit Hotel Website

FSP attendees will receive a special room rate that starts at $329 per night, plus taxes. The group rate is guaranteed for reservations made on or before June 20, 2024 or until the room block is filled.
Attendees must register for the conference first and then once registered will receive access to the discounted room block through the confirmation email.



Accreditation Information


Please join us at the FSP 2024 Summer Pathology Conference taking place on July 12-14, 2024 at the Eau Palm Beach Resort & Spa.  Exhibitors will connect with 100-150 pathologists during the conference as well as engage in over 15 hours of face to face time with attendees.

Other benefits include:


  • Pre and post attendee lists.
  • Benefit from listings on onsite signage, virtual exhibit hall and the FSP onsite guide.
  • Gain maximum exposure with prize giveaways and breaks scheduled in the exhibit hall.
  • Receive between 2-6 complimentary badges to access the exhibit hall dependent on sponsorship level chosen.

Exhibitors Registration is Closed Now

View/Download Prospectus

Satellite Events


Special Events


Confirmed Exhibitors

APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services. Please visit our website at www.apsmedbill.com.

Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals including Food, Environmental and Forensics, Diagnostics, Pharmaceutical, Chemical and Energy, and Research.
We provide trusted answers, together with our customers, through our integrated pathology solutions. Our portfolio includes a full range of world-class products, service and support that meet the individual needs of your lab and enables efficient, cost-effective and accurate diagnosis for cancer patients.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.


Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.

Get your molecular biomarker results in hours, not days or weeks!  The revolutionary Idylla™ platform by Biocartis is a RAPID, automated PCR system that offers accurate molecular information from tissue or plasma in any laboratory setting. Get your results within 85-180 minutes from sample input, with under three minutes of hands-on time.  
For more information, visit our website: www.biocartis.com/us





Blueprint Medicines is a global precision therapy company that aims to invent transformative medicines for people with cancer and hematologic disorders. Applying an approach that is both precise and agile, we seek to create therapies that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease. Since 2011, we have leveraged our research platform, including expertise in molecular targeting and world-class drug design capabilities, to rapidly and reproducibly translate science into a broad pipeline of precision therapies. Today, we are delivering our approved medicines to patients in the United States and Europe, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.


Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit www.CarisLifeSciences.com or follow us on Twitter (@CarisLS).



Cleveland Clinic Laboratories is a full-service, national reference laboratory dedicated to providing world-class care. Our laboratories offer high-quality, clinically impactful pathology and laboratory diagnostics services combined with readily available consultation from experienced pathologists and laboratory scientists.

Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia.

With over 12 years' experience in laser cassette printing technology, General Data Healthcare is the leader in providing barcode identification and tracking solutions. Our LaserTrack cassette printers consistently produce sharp readable text and barcodes that deliver nearly 100% scan rates, and SlideTrack ESPO delivers automated direct to slide printing and worry-free control slides. Our H&Easyâ„¢ Stain Optimization Service can save you money. See if we can match or improve upon your existing H&E's. Also new: schedule a live interactive demo without leaving your lab, visit us at www.general-data.com/healthcare to schedule your demo!

GoPath Diagnostics, a diagnostic reference lab specializing in cancer genetics and molecular pathology, utilizes cutting-edge testing technologies and has global technology-only options. With GeneticsNow, OncoTarget, and OncoTracking, innovative solutions are developed through skilled teamwork and industry partnerships. GoPath conducts a range of tests including IHC, FISH, molecular PCR, cytogenetics, and NGS.

Grundium provides an all in one, low investment and high value digital pathology solution which is ideal for interoperative FROZEN, FNA and ROSE workflows with one of the sharpest, high quality images in the industry. 


Hankins Consulting seamlessly integrates a wealth of expertise, with a collective experience of over 100 years. We specialize in comprehensive diagnostic laboratory build-outs, strategic lab management consulting, licensing and compliance services. Our offerings extend to expert staff acquisition and training, ensuring a holistic approach to your laboratory needs. Additionally, we excel in supply fulfillment, kitting services, and offer robust 3PL solutions.

Molecular diagnostic testing for indeterminate thyroid nodules utilizing multi platform testing. ThyGeNEXT is an oncogenic mutation panel that helps identify malignant thyroid nodules and ThyraMIR is a proprietary microRNA gene expression assay that helps to clarify the risk of cancer in thyroid nodules.


Specialty diagnostics at every stage of cancer care. We help you navigate the complex treatment landscape, connecting insights from patients, trials, health systems and managed care partners to power decisions that improve patient outcomes.


Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital based physician. Our company provides complete accounts receivable management services for hospital-based physicians.


At Merck, our goal is to translate breakthrough science into innovative oncology medicines.  As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry. 

As a CLIA-certified/CAP accredited full-service laboratory of over 30 years, Michigan Medicine Laboratories combines the scientific rigor and infrastructure investment of a top academic research institution with the efficiency, flexibility, and responsiveness of a private reference lab. Our menu consists of over 1,800 tests and 60 expert consultants within 18 subspecialties available across the country. Partnering with Michigan Medicine Laboratories means gaining acces to one of the largest, most productive pathology enterprises in academic medicine, with faculty equally passionate about scientific discovery and service excellence. By making nationally recognized faculty and state-of-the-science technology easily accessible, we help you meet your practice's needs for on-time, accurate pathology results. 


"MilliporeSigma is a global science and technology company determined to solve the toughest problems in life science. Our tools, services, and digital platforms empower scientists and engineers at every stage, helping to deliver scientific breakthroughs.
We offer cutting-edge technologies, high-quality products, and novel services for diagnostics, research, development, and the manufacturing of biologics and novel therapies. We are dedicated to making research and biotech production simpler, faster, and more successful. Our dedication to the customer experience extends from the lab to our e-commerce platform, which connects scientists in nearly every country with the products, publications, and technical expertise needed to advance their research, manufacturing, and development further and faster.

MSN Healthcare Solutions (MSN) provides pathologists with innovative, client-centric billing and practice management services. MSN’s experienced team partners closely with clients to meet their specific business needs, and we develop long-term relationships as trusted advisors. We deliver sustainable improvements through outstanding customer service, leading industry knowledge, and innovative technology. Our excellent reputation is based on our client-centric approach, which means doing what’s right for our clients by putting their interests first.

NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore. 

Roche Indy is the North American headquarters of the world's largest biotech company, where more than 4,000 people work together to provide insights that help people around the world manage and improve personal health conditions. We lead the industry in the development of diagnostics products for cancer, cardiac health, infectious diseases, women's health and in diabetes management. Diagnostics informs 70 percent of clinical decisions, including the prevention, identification and treatment of diseases, and are a critical part of modern medicine as care becomes more personalized.


"Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We're driven by a singular mission to make a difference for people impacted by cancer.  
As an industry leader in antibody drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology. We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents."

ThyroSeq® Genomic Classifier is a comprehensive and innovative test for thyroid nodules and cancer that utilizes NGS technology to analyze both DNA and RNA of 112 thyroid-related genes. Using a proprietary genomic classifier, Thyroseq provides comprehensive diagnostic and prognostic information, empowering physicians to individualize patient management. Thyroseq offers the most accurate diagnosis of benign or malignant disease in thyroid nodules. For more information, visit www.thyroseq.com.


Our goal is to build awareness around an aggressive and deadly hematologic malignancy called Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).  There is a newly approved therapy for BPDCN and we aim to shorten the time to diagnosis so patients can be placed on appropriate therapy in a timely manner.


At UHealth – University of Miami Health System, we offer exceptional, patient-centered, evidence-based medical care. Our team of 1,800 highly skilled and compassionate health care professionals provide personalized care for every patient. As South Florida’s only academic-based medical center, UHealth is home to the #1 ranked eye hospital in the US, Bascom Palmer Eye Institute, South Florida’s only NCI-designated cancer center, Sylvester Comprehensive Cancer Center, and offers expertise in 100 medical specialties across 30 locations.
At UHealth International, our multilingual and multicultural team supports your patients before, during and after their visit.
•        Coordination of care
•        Secure access to electronic patient portal
•        Medical visa letters
•        Language services
•        Financial and insurance services  


Veracyte is a pioneering genomic diagnostics company. Our tests provide trustworthy and actionable ANSWERS that improve patient care when diagnostic test results are uncertain. Our tests leverage innovations in genomic technology and machine learning to enable a significantly more confident diagnosis than currently possible in challenging diseases such as thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. We are creating new standards of care in the diagnosis of these diseases by enabling more patients to avoid unnecessary invasive procedures, speeding time to diagnosis and removing costs from the healthcare system.



Coming soon


Networking Events




Resident Jeopardy


Confirmed Sponsors


Rare and Interesting Case Competition